Results 261 to 270 of about 357,421 (301)
Some of the next articles are maybe not open access.
Current Opinion in Oncology, 2009
This review is intended to provide information on recent advancements in renal cell carcinoma (RCC) treatments as well as give insight on present-day clinical and molecularly based biomarker studies.A review of recent literature regarding RCC epidemiology and clinical prognostic factors will be provided.
Jorge A, Garcia +2 more
openaire +4 more sources
This review is intended to provide information on recent advancements in renal cell carcinoma (RCC) treatments as well as give insight on present-day clinical and molecularly based biomarker studies.A review of recent literature regarding RCC epidemiology and clinical prognostic factors will be provided.
Jorge A, Garcia +2 more
openaire +4 more sources
Current Opinion in Oncology, 1998
Renal cell carcinoma (RCC) continues to be a frustrating tumor for clinicians to manage and treat. Progress has been made in the identification of risk factors, particularly dietary risk factors. An increased risk has been seen with frequent consumption of fried meat and poultry.
P A, Godley, M A, Escobar
openaire +2 more sources
Renal cell carcinoma (RCC) continues to be a frustrating tumor for clinicians to manage and treat. Progress has been made in the identification of risk factors, particularly dietary risk factors. An increased risk has been seen with frequent consumption of fried meat and poultry.
P A, Godley, M A, Escobar
openaire +2 more sources
Hospital Practice, 1987
A doubling in tumor size increases metastases 10-fold and reduces surgical curability drastically. Early diagnosis, abetted by CT and ultrasound scanning, is critical.
J E, Rotolo, W M, O'Brien, J H, Lynch
openaire +2 more sources
A doubling in tumor size increases metastases 10-fold and reduces surgical curability drastically. Early diagnosis, abetted by CT and ultrasound scanning, is critical.
J E, Rotolo, W M, O'Brien, J H, Lynch
openaire +2 more sources
Current Opinion in Oncology, 2002
Renal cell carcinoma continues to be a difficult malignancy to treat because of its ability to spread asymptomatically and its inherent resistance to conventional chemotherapy. However, molecular genetic studies bring new insights into the pathogenesis of this disorder and may provide new targets against which novel chemotherapeutic agents could be ...
Paul, Godley, Steven W, Kim
openaire +2 more sources
Renal cell carcinoma continues to be a difficult malignancy to treat because of its ability to spread asymptomatically and its inherent resistance to conventional chemotherapy. However, molecular genetic studies bring new insights into the pathogenesis of this disorder and may provide new targets against which novel chemotherapeutic agents could be ...
Paul, Godley, Steven W, Kim
openaire +2 more sources
Current Opinion in Oncology, 2007
This review highlights recent contributions to the biology and treatment of renal cell carcinoma, the expanded use of antiangiogenic agents as well as interest in other inhibitory drug mechanisms. In addition, recent findings are reported on biomarkers which are undergoing investigation as correlative prognostic indicators of either survival or ...
W Kimryn, Rathmell +2 more
openaire +2 more sources
This review highlights recent contributions to the biology and treatment of renal cell carcinoma, the expanded use of antiangiogenic agents as well as interest in other inhibitory drug mechanisms. In addition, recent findings are reported on biomarkers which are undergoing investigation as correlative prognostic indicators of either survival or ...
W Kimryn, Rathmell +2 more
openaire +2 more sources
The Lancet
The landscape of the management of renal cell carcinoma has evolved substantially in the last decade, leading to improved survival in localised and advanced disease. We review the epidemiology, pathology, and diagnosis of renal cell carcinoma and discuss the evidence for current management strategies from localised to metastatic disease.
Matthew, Young +7 more
openaire +4 more sources
The landscape of the management of renal cell carcinoma has evolved substantially in the last decade, leading to improved survival in localised and advanced disease. We review the epidemiology, pathology, and diagnosis of renal cell carcinoma and discuss the evidence for current management strategies from localised to metastatic disease.
Matthew, Young +7 more
openaire +4 more sources
Current Opinion in Oncology, 1993
Renal cell carcinoma remains a challenge for oncologists, with only 20% of patients being cured by surgical removal of the involved kidney and a handful of patients with advanced disease being cured by surgery, immunotherapy, or both. Although advances in early detection, recognition of high-risk groups, and chemotherapy remain disappointing, advances ...
openaire +7 more sources
Renal cell carcinoma remains a challenge for oncologists, with only 20% of patients being cured by surgical removal of the involved kidney and a handful of patients with advanced disease being cured by surgery, immunotherapy, or both. Although advances in early detection, recognition of high-risk groups, and chemotherapy remain disappointing, advances ...
openaire +7 more sources
Current Opinion in Oncology, 2003
Renal cell carcinoma (RCC) continues to present a diagnostic and therapeutic challenge. The increased use of abdominal imaging studies does not appear to completely account for the rising incidence of RCC. Alcohol consumption has been found to be a possible protective factor among women in a recent study, but among women with children, RCC risk may ...
Young E, Whang, Paul A, Godley
openaire +2 more sources
Renal cell carcinoma (RCC) continues to present a diagnostic and therapeutic challenge. The increased use of abdominal imaging studies does not appear to completely account for the rising incidence of RCC. Alcohol consumption has been found to be a possible protective factor among women in a recent study, but among women with children, RCC risk may ...
Young E, Whang, Paul A, Godley
openaire +2 more sources
Advances in Anatomic Pathology, 2022
The World Health Organization (WHO) recommends grading of clear cell renal cell carcinoma (RCC) and papillary RCC using the WHO/International Society of Urological Pathology (ISUP) grade, which is primarily based on nuclear features. As the spectrum of RCC continues to evolve, with more recently described subtypes in the past decade, literature ...
Paner, Gladell P +4 more
openaire +2 more sources
The World Health Organization (WHO) recommends grading of clear cell renal cell carcinoma (RCC) and papillary RCC using the WHO/International Society of Urological Pathology (ISUP) grade, which is primarily based on nuclear features. As the spectrum of RCC continues to evolve, with more recently described subtypes in the past decade, literature ...
Paner, Gladell P +4 more
openaire +2 more sources
Current Opinion in Oncology, 2001
Several renal cell carcinoma (RCC) prognostic factors show promise, including K1-67, p53/mdm-2, and vascular endothelial growth factor. The combination of increased incidence of RCC and diagnosis during earlier stages has generated interest in local therapeutic options.
P A, Godley, M, Taylor
openaire +2 more sources
Several renal cell carcinoma (RCC) prognostic factors show promise, including K1-67, p53/mdm-2, and vascular endothelial growth factor. The combination of increased incidence of RCC and diagnosis during earlier stages has generated interest in local therapeutic options.
P A, Godley, M, Taylor
openaire +2 more sources